Your browser doesn't support javascript.
Antipsychotic use and psychiatric disorders in COVID-19.
Ferraris, Augusto; Angriman, Federico; Szmulewicz, Alejandro G.
  • Ferraris A; School of Medicine, University of Buenos Aries, Buenos Aires C111 3AAD, Argentina.
  • Angriman F; Institute for Health Policy, Management & Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
  • Szmulewicz AG; Department of Epidemiology, Harvard TH Chan School of Public Health, Boston, MA, USA.
Lancet Healthy Longev ; 2(2): e64, 2021 02.
Article in English | MEDLINE | ID: covidwho-1062713
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antipsychotic Agents / COVID-19 Drug Treatment / Mental Disorders Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Country/Region as subject: Europa Language: English Journal: Lancet Healthy Longev Year: 2021 Document Type: Article Affiliation country: S2666-7568(20)30063-5

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antipsychotic Agents / COVID-19 Drug Treatment / Mental Disorders Type of study: Cohort study / Observational study / Prognostic study Limits: Humans Country/Region as subject: Europa Language: English Journal: Lancet Healthy Longev Year: 2021 Document Type: Article Affiliation country: S2666-7568(20)30063-5